MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, LPCN made $119,397 in revenue. -$3,683,533 in net income. Net profit margin of -3085.11%.

Income Overview

Revenue
$119,397
Net Income
-$3,683,533
Net Profit Margin
-3085.11%
EPS
-$0.54
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
119,397 870,542.5* 114,574 622,849
Research and development
2,764,394 1,320,619.75* 2,707,777 2,136,769
General and administrative
1,204,467 1,276,732* 767,837 890,433
Total operating expenses
3,968,861 2,597,351.75* 3,475,614 3,027,202
Operating loss
-3,849,464 -1,726,809.25* -3,361,040 -2,404,353
Unrealized loss on warrant liability
---0
Interest and investment income
177,570 184,806.5 174,208 198,637
Total other income
177,570 184,806.5* 174,208 198,637
Loss before income tax expense
-3,671,894 -1,542,002.75* -3,186,832 -2,205,716
Income tax expense
-200* -0
Net loss attributable to common shareholders
-3,671,894 -1,542,202.75* --
Net unrealized loss on marketable investment securities
-11,639 -1,173.25* --
Net loss attributable to common shareholders
---3,186,832 -2,205,716
Comprehensive loss
-3,683,533 -1,543,376 --
Basic EPS
-0.54 -0.277 -0.59 -0.41
Diluted EPS
-0.54 -0.243 -0.59 -0.41
Basic Average Shares
6,795,002 5,581,507 5,413,149 5,351,957
Diluted Average Shares
6,795,002 6,359,608 5,413,149 5,351,957
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$3,683,533 Net lossattributable to common...-$3,671,894 Net unrealized losson marketable...-$11,639 Interest and investmentincome$177,570 Loss before incometax expense-$3,671,894 Total other income$177,570 Operating loss-$3,849,464 Total revenues$119,397 Total operatingexpenses$3,968,861 Research and development$2,764,394 General andadministrative$1,204,467

Lipocine Inc. (LPCN)

Lipocine Inc. (LPCN)